Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
in
Blood vessels
/ Bone marrow
/ CD8 antigen
/ Cell proliferation
/ Effector cells
/ Immune status
/ Immunoregulation
/ Lymphocytes
/ Lymphocytes T
/ Memory cells
/ Patients
/ Pelvis
/ Prostate cancer
/ Radiation therapy
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
by
in
Blood vessels
/ Bone marrow
/ CD8 antigen
/ Cell proliferation
/ Effector cells
/ Immune status
/ Immunoregulation
/ Lymphocytes
/ Lymphocytes T
/ Memory cells
/ Patients
/ Pelvis
/ Prostate cancer
/ Radiation therapy
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
in
Blood vessels
/ Bone marrow
/ CD8 antigen
/ Cell proliferation
/ Effector cells
/ Immune status
/ Immunoregulation
/ Lymphocytes
/ Lymphocytes T
/ Memory cells
/ Patients
/ Pelvis
/ Prostate cancer
/ Radiation therapy
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
Journal Article
Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
2022
Request Book From Autostore
and Choose the Collection Method
Overview
PurposeThe influence of radiotherapy on patient immune cell subsets has been established by several groups. Following a previously published analysis of immune changes during and after curative radiotherapy for prostate cancer, this analysis focused on describing correlations of changes of immune cell subsets with radiation treatment parameters.Patients and methodsFor 13 patients treated in a prospective trial with radiotherapy to the prostate region (primary analysis) and five patients treated with radiotherapy to prostate and pelvic nodal regions (exploratory analysis), already published immune monitoring data were correlated with clinical data as well as radiation planning parameters such as clinical target volume (CTV) and volumes receiving 20 Gy (V20) for newly contoured volumes of pelvic blood vessels and bone marrow.ResultsMost significant changes among immune cell subsets were observed at the end of radiotherapy. In contrast, correlations of age and CD8+ subsets (effector and memory cells) were observed early during and 3 months after radiotherapy. Ratios of T cells and T cell proliferation compared to baseline correlated with CTV. Early changes in regulatory T cells (Treg cells) and CD8+ effector T cells correlated with V20 of blood vessels and bone volumes.ConclusionsPatient age as well as radiotherapy planning parameters correlated with immune changes during radiotherapy. Larger irradiated volumes seem to correlate with early suppression of anti-cancer immunity. For immune cell analysis during normofractionated radiotherapy and correlations with treatment planning parameters, different time points should be looked at in future projects.Trial registration number:NCT01376674, 20.06.2011
Publisher
Springer Nature B.V
Subject
This website uses cookies to ensure you get the best experience on our website.